Answers are grounded in this paper and cite their sources.
OBJECTIVES: Renal transplant recipients (RTRs) are at increased risk of keratinocyte cancer (KC) development due to immunosuppression. A single-centre retrospective cohort study was conducted to determine the incidence, risk factors and impact on mortality of KCs in RTRs. METHODS: All RTRs attending an adult transplant dermatology service in Victoria, Australia between 1 January 2004 and 1 March 2020 were included. Age, gender, age at transplantation and immunosuppression regimen were recorded at baseline. At each encounter, a whole body examination was performed, and histologically confirmed KCs were recorded. Linkage was performed with the Australia and New Zealand Dialysis and Transplant Registry to obtain mortality data. RESULTS: Of the 414 participants, 162 (39%) were diagnosed with a KC (basal cell carcinoma [BCC], invasive squamous cell carcinoma [SCC], or squamous cell carcinoma in situ [SCCis]). A total of 1110 KCs were diagnosed. Of these, 451 (40.63%) were invasive SCC, 341 (30.72%) were BCC and 318 (28.65%) were SCCis. Risk factors for KC included skin phototype 1 or 2, exposure to mycophenolate (aHR 2.19, CI 1.39-3.46, p = 0.001), male gender (aHR 1.84, CI 1.27-2.68, p = 0.01), older age (aHR 1.28, CI 1.19-1.38, p < 0.001) and longer transplant duration (aHR 1.15, CI 1.04-1.28, p = 0.005). Eighty-two (19.8%) patients died, most commonly of malignancy (n = 21, 25.6%). Diagnosis of invasive SCC was associated with mortality in univariate analysis (HR 2.85; 95% CI, 1.82-4.46 p < 0.001) but narrowly failed to reach significance on multivariable analysis (HR 1.59, CI 0.92-2.76, p = 0.098). CONCLUSIONS: These findings highlight the burden of KC-related morbidity and mortality in RTRs. Vigilant monitoring is of vital importance in this population.
No takes yet. Share an insight, caveat, or question.
Mumford et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: